{"meta":{"query_hash":"e3ea89210aa8","filters":{"venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease"},"cohort_total":16,"direct_labels_cover":0,"predictions_cover":16,"exported":16,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e3ea89210aa8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+treatment+options+in+infectious+diseases%2FCurrent+treatment+options+in+infectious+disease"},"results":[{"id":"W1967898453","doi":"10.1007/s40506-014-0015-3","title":"Antimicrobial Stewardship Programs: Appropriate Measures and Metrics to Study their Impact","year":2014,"lang":"en","type":"review","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Antimicrobial stewardship; Medicine; Stewardship (theology); Antimicrobial; Psychological intervention; Antibiotic resistance; Intensive care medicine; Metric (unit); Population; Environmental health; Risk analysis (engineering); Nursing; Business; Marketing; Antibiotics; Microbiology","score_opus":0.05364443792420077,"score_gpt":0.35673047050740103,"score_spread":0.30308603258320027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967898453","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047164436,0.110601656,0.52601326,0.22869217,0.0058230236,0.0054492126,0.0074054603,0.0036723006,0.06517845],"genre_scores_gemma":[0.31776503,0.047509998,0.6006692,0.016086798,0.003961497,0.006028654,0.0033624088,0.0008650501,0.0037512651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8515593,0.07565083,0.018305266,0.0039774715,0.04798406,0.0025231598],"domain_scores_gemma":[0.72496665,0.13393942,0.039513808,0.019611277,0.069534376,0.012434468],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12611106,0.0033415172,0.004292787,0.011670174,0.0020166796,0.016060561,0.003076459,0.00513511,0.0031659007],"category_scores_gemma":[0.29970655,0.0011057336,0.0018882485,0.015344139,0.0057575735,0.027708456,0.008183756,0.0075960243,0.0018330399],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031279286,0.0011568333,0.11643052,0.006420012,0.0010307434,0.00014530511,0.003109994,0.008070493,0.00089001626,0.13034439,0.071848825,0.6602401],"study_design_scores_gemma":[0.00027160725,0.0038537758,0.14659154,0.030495934,0.0010170621,0.000609871,0.01290316,0.028243301,0.0050164564,0.39898282,0.37126094,0.00075344724],"about_ca_topic_score_codex":0.0058287345,"about_ca_topic_score_gemma":0.004747765,"teacher_disagreement_score":0.87388897,"about_ca_system_score_codex":0.008518035,"about_ca_system_score_gemma":0.018027402,"threshold_uncertainty_score":0.666947},"labels":[],"label_agreement":null},{"id":"W1999941464","doi":"10.1007/s40506-013-0005-x","title":"Prevention of Malaria in Travelers: Bite Avoidance and Chemoprophylactic Measures","year":2013,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Malaria Research and Control","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Mefloquine; Medicine; Proguanil; Malaria; Primaquine; Malaria prophylaxis; Atovaquone; Chloroquine; Chemoprophylaxis; Tolerability; Doxycycline; Travel medicine; Adverse effect; Pharmacology; Intensive care medicine; Plasmodium falciparum; Surgery; Immunology; Antibiotics; Psychiatry","score_opus":0.027969230764751253,"score_gpt":0.3183546613225047,"score_spread":0.2903854305577534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999941464","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64663404,0.25063708,0.0076694316,0.049583163,0.0016781344,0.001351439,0.00054893165,0.00046606397,0.04143168],"genre_scores_gemma":[0.8836512,0.08588534,0.013667838,0.004551028,0.002707422,0.00055176334,0.00044552697,0.000026201435,0.008513653],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997483,0.00009504284,0.000017088558,0.000016600545,0.00006893412,0.000054090706],"domain_scores_gemma":[0.9996675,0.000055181292,0.00008789458,0.0000138401265,0.0000631194,0.00011232083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004473683,0.00049960834,0.00073948695,0.00054212037,0.00057209603,0.0003928585,0.00065313047,0.0008954591,0.0050948947],"category_scores_gemma":[0.0014895288,0.00017331296,0.000532311,0.00028783208,0.0002499033,0.00054340414,0.0006245628,0.0012402543,0.00046509932],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013628639,0.006324813,0.049434107,0.003005164,0.0002314913,0.00080122805,0.00039541276,0.0005773234,0.004672312,0.0009591689,0.016907131,0.9153289],"study_design_scores_gemma":[0.0016682572,0.027394475,0.89222485,0.0063769715,0.00091427175,0.008913542,0.0024792256,0.0026364557,0.005314614,0.003370297,0.048585694,0.00012140598],"about_ca_topic_score_codex":0.0033112264,"about_ca_topic_score_gemma":0.0069598956,"teacher_disagreement_score":0.0050948947,"about_ca_system_score_codex":0.00025847176,"about_ca_system_score_gemma":0.00094791525,"threshold_uncertainty_score":0.017044067},"labels":[],"label_agreement":null},{"id":"W2170555701","doi":"10.1007/s40506-015-0047-3","title":"Therapeutic Approaches for New World Hantaviruses","year":2015,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Laboratory of Public Health; University of Alberta; University of Manitoba; Children's Hospital of Winnipeg; Children's Hospital Research Institute of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Medicine; Intensive care medicine; Hantavirus Infection; Hantavirus; Prodrome; Hantavirus pulmonary syndrome; Disease; Immunology; Virus; Internal medicine; Psychiatry","score_opus":0.17243254402827282,"score_gpt":0.378064727760595,"score_spread":0.2056321837323222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170555701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14676568,0.71108407,0.044378944,0.017064957,0.004739755,0.0007772879,0.00044203288,0.00038702224,0.07436026],"genre_scores_gemma":[0.57216483,0.35852733,0.02943313,0.0055722552,0.0029577322,0.0008664303,0.0007804036,0.00006740642,0.029630443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998627,0.000041080788,0.00000781867,0.000017025004,0.000028806118,0.000042466283],"domain_scores_gemma":[0.99992204,0.000027443517,0.000015883497,0.0000075003004,0.000012306282,0.000014909046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063309283,0.00032701515,0.00043420127,0.00038302568,0.0003978953,0.0008901474,0.0004877174,0.00062691554,0.0065699113],"category_scores_gemma":[0.00030561685,0.00010336723,0.00042291186,0.00018689301,0.00049779273,0.0009098349,0.00059468165,0.0010404354,0.00065859826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010275772,0.0010362604,0.0021347695,0.0028363997,0.00022585076,0.0013927557,0.00071989786,0.0014054754,0.10902296,0.04595897,0.01772468,0.81651443],"study_design_scores_gemma":[0.0011769678,0.0056885546,0.00818517,0.0017518714,0.00058690977,0.008083023,0.0014767452,0.004013781,0.056676984,0.03723127,0.8750542,0.00007448965],"about_ca_topic_score_codex":0.00045770145,"about_ca_topic_score_gemma":0.00084473134,"teacher_disagreement_score":0.0065699113,"about_ca_system_score_codex":0.00040356486,"about_ca_system_score_gemma":0.00044569676,"threshold_uncertainty_score":0.021978557},"labels":[],"label_agreement":null},{"id":"W2470638608","doi":"10.1007/s40506-016-0080-x","title":"Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy","year":2016,"lang":"en","type":"review","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Agency of Canada","funders":"","keywords":"Medicine; Pegylated interferon; Hepatitis B virus; Immunology; Hepatitis B; Virology; Antigen; Interferon; Chronic hepatitis; Virus; Ribavirin","score_opus":0.06230528556141114,"score_gpt":0.40134875814161636,"score_spread":0.33904347258020523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470638608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066276145,0.99924767,0.00006178223,0.000115098046,0.00010606505,0.000006776206,0.000021963158,0.0000044522208,0.00036992808],"genre_scores_gemma":[0.00050481025,0.99887615,0.00019193029,0.00011272114,0.00012176293,0.000012004008,0.000033946784,0.0000011358259,0.0001454715],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9990237,0.00022737702,0.00028568273,0.00012913586,0.00029347758,0.000040696843],"domain_scores_gemma":[0.997721,0.0012648811,0.0003974676,0.000042022984,0.00050870876,0.00006590471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014202123,0.0013076545,0.002344148,0.0067456667,0.0002934338,0.0012979357,0.0014923272,0.0010912041,0.0037723493],"category_scores_gemma":[0.0036372617,0.00044162368,0.0012433437,0.005588608,0.00055576593,0.001514971,0.0005563479,0.0011515926,0.0015219903],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012932067,0.00008045241,0.00055954105,0.06511534,0.00025992186,0.00019782959,0.00006585738,0.00020432711,0.0006197313,0.00095271686,0.022696178,0.9091189],"study_design_scores_gemma":[0.00009541069,0.00028459495,0.0053254548,0.05694298,0.0016685359,0.0051855217,0.00018023692,0.00021490265,0.0009940733,0.0016713595,0.92736286,0.000074179814],"about_ca_topic_score_codex":0.0019980501,"about_ca_topic_score_gemma":0.0025478748,"teacher_disagreement_score":0.0067456667,"about_ca_system_score_codex":0.00073477626,"about_ca_system_score_gemma":0.0016798642,"threshold_uncertainty_score":0.012619734},"labels":[],"label_agreement":null},{"id":"W2471768500","doi":"10.1007/s40506-016-0081-9","title":"The Role of Clinical Virology Laboratory and the Clinical Virology Laboratorian in Ensuring Effective Surveillance for Influenza and Other Respiratory Viruses: Points to Consider and Pitfalls to Avoid","year":2016,"lang":"en","type":"review","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Laboratory of Public Health; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Public health; Intensive care medicine; Influenza A virus subtype H5N1; Orthomyxoviridae; Virology; Influenza A virus; Virus; Pathology","score_opus":0.14462113523409809,"score_gpt":0.5068559397668909,"score_spread":0.36223480453279283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471768500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006784782,0.99312145,0.0002651333,0.0051547075,0.00062275113,0.000006764633,0.0000115281055,0.000009601891,0.0007402511],"genre_scores_gemma":[0.0015610629,0.99214584,0.0018987891,0.0029550109,0.0010748754,0.000017492881,0.0000252421,0.00000541383,0.00031634598],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943104,0.0023282366,0.0011434398,0.00044100563,0.0014620774,0.0003147919],"domain_scores_gemma":[0.97767013,0.01452238,0.0019606468,0.00044780015,0.0044658706,0.0009332102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012579374,0.0011786973,0.0032000928,0.0023566396,0.00082289986,0.004015149,0.0030146528,0.004678222,0.0036257124],"category_scores_gemma":[0.015795683,0.000581597,0.0013085396,0.0021246225,0.0023080409,0.006096834,0.0022922591,0.0063333795,0.0020695983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008599774,0.00007216062,0.0012650081,0.026985642,0.00023132838,0.00033023098,0.00041016037,0.00017617039,0.00049499416,0.00644402,0.04479024,0.91871405],"study_design_scores_gemma":[0.000051677787,0.00013155547,0.0026514812,0.052659944,0.00039514003,0.0016590221,0.0010351577,0.00013049909,0.00028175223,0.005455057,0.9354767,0.00007210034],"about_ca_topic_score_codex":0.004591374,"about_ca_topic_score_gemma":0.008545975,"teacher_disagreement_score":0.012579374,"about_ca_system_score_codex":0.0018684542,"about_ca_system_score_gemma":0.010131363,"threshold_uncertainty_score":0.06652683},"labels":[],"label_agreement":null},{"id":"W2531053673","doi":"10.1007/s40506-016-0098-0","title":"New Era of TB Drug Discovery and Its Impact on Disease Management","year":2016,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tuberculosis; Drug; Disease; Infectious disease (medical specialty); Drug discovery; Mycobacterium tuberculosis; Drug development; Intensive care medicine; Antibiotics; Virology; Pharmacology; Microbiology; Bioinformatics; Biology; Pathology","score_opus":0.026451864067332298,"score_gpt":0.3659218639049909,"score_spread":0.3394699998376586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531053673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065728957,0.7022636,0.0029060359,0.2620021,0.006499845,0.000018363156,0.00029485315,0.00007853345,0.019363848],"genre_scores_gemma":[0.12144944,0.7686721,0.006775852,0.0603098,0.035993904,0.00005464858,0.00023540301,0.00006729163,0.0064415657],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99661595,0.0012386423,0.000309639,0.0003667404,0.0010551482,0.0004140013],"domain_scores_gemma":[0.9827785,0.010006674,0.0016675069,0.0008648268,0.0025982996,0.0020842047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010194744,0.0006360405,0.0016399878,0.0025188208,0.0011882982,0.006940442,0.0013810877,0.004818571,0.0150554925],"category_scores_gemma":[0.011587539,0.00040976878,0.0009710884,0.0021778399,0.0053625815,0.012298347,0.0028227055,0.006794603,0.0023909404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079167465,0.00054467795,0.0067945067,0.0044953213,0.00014931579,0.00087142945,0.0008826737,0.0011476189,0.0032760906,0.19572678,0.116619356,0.66870064],"study_design_scores_gemma":[0.00010569683,0.00064445735,0.007921815,0.0039653787,0.00014200511,0.0020579905,0.0016263098,0.0016853744,0.0011028801,0.14743558,0.8332113,0.00010128952],"about_ca_topic_score_codex":0.0015247798,"about_ca_topic_score_gemma":0.0031311603,"teacher_disagreement_score":0.0150554925,"about_ca_system_score_codex":0.0036963213,"about_ca_system_score_gemma":0.006118523,"threshold_uncertainty_score":0.05391562},"labels":[],"label_agreement":null},{"id":"W2533816251","doi":"10.1007/s40506-016-0090-8","title":"Dilemmas and Pitfalls in Rubella Laboratory Diagnostics in Low Prevalence or Elimination Settings","year":2016,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada; University of Alberta; Provincial Laboratory of Public Health","funders":"","keywords":"Rubella; Medicine; Congenital rubella syndrome; Context (archaeology); Rubella virus; Epidemiology; Immunology; Pediatrics; Vaccination; Measles; Pathology","score_opus":0.020372206183625893,"score_gpt":0.3187610115339236,"score_spread":0.2983888053502977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533816251","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018707313,0.06699149,0.013655403,0.87365043,0.007540967,0.000119837074,0.00011516401,0.00027166787,0.018947808],"genre_scores_gemma":[0.6431849,0.069480754,0.074369706,0.17739117,0.031332217,0.00031623873,0.00018593144,0.00022667152,0.0035124333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95169663,0.032278378,0.00548431,0.0016839149,0.0064663384,0.0023903535],"domain_scores_gemma":[0.85187626,0.108907044,0.0077243317,0.0027246661,0.019833185,0.008934502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.086071305,0.0008050324,0.0016506762,0.003263442,0.0052636554,0.009053112,0.0043488354,0.0061368532,0.004685806],"category_scores_gemma":[0.16267696,0.00082333945,0.00095456204,0.0017334766,0.012664413,0.013055865,0.0055982517,0.012715953,0.001659489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055911375,0.0004925917,0.083083995,0.0037649786,0.00017798277,0.018383227,0.014355342,0.0017778759,0.0011566936,0.05387294,0.19415352,0.6282217],"study_design_scores_gemma":[0.00038885078,0.00091719354,0.04755454,0.028662637,0.00047699688,0.080766514,0.120301805,0.008635951,0.0030205608,0.39211395,0.3163076,0.0008533739],"about_ca_topic_score_codex":0.0076549607,"about_ca_topic_score_gemma":0.015373372,"teacher_disagreement_score":0.086071305,"about_ca_system_score_codex":0.0038614392,"about_ca_system_score_gemma":0.009676603,"threshold_uncertainty_score":0.455194},"labels":[],"label_agreement":null},{"id":"W2535468295","doi":"10.1007/s40506-016-0092-6","title":"Nontuberculous Mycobacteria in Cystic Fibrosis","year":2016,"lang":"en","type":"review","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Rockyview General Hospital; University of Calgary","funders":"","keywords":"Medicine; Nontuberculous mycobacteria; Azithromycin; Amikacin; Cystic fibrosis; Mycobacterium abscessus; Ethambutol; Bronchiectasis; Antibiotics; Tolerability; Internal medicine; Culture conversion; Lung; Intensive care medicine; Immunology; Tuberculosis; Mycobacterium; Pathology; Rifampicin; Microbiology; Adverse effect; Sputum","score_opus":0.04548966144776308,"score_gpt":0.3791195640703563,"score_spread":0.33362990262259323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535468295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12138991,0.8101825,0.002739057,0.026044853,0.003279029,0.0003073163,0.00071177055,0.00018624112,0.035159323],"genre_scores_gemma":[0.6180598,0.347902,0.0035671962,0.0097499965,0.008546327,0.00022099125,0.0013749489,0.00005246685,0.010526281],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989287,0.0002705918,0.00023599366,0.00009588808,0.00028905866,0.00017973394],"domain_scores_gemma":[0.99876803,0.00035889813,0.00032922253,0.000050187682,0.00023244714,0.00026122652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001205879,0.00043733045,0.0007792361,0.0018462077,0.0008807132,0.0010223653,0.00047862064,0.0017530492,0.0030119508],"category_scores_gemma":[0.0030335041,0.00019057406,0.0004722484,0.0011956305,0.0008019418,0.0010015526,0.0007858501,0.0014232695,0.0012144737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007700508,0.00049865944,0.30934578,0.005239,0.00014193359,0.047734316,0.001458874,0.00027384778,0.00542625,0.0046543847,0.06692488,0.55753213],"study_design_scores_gemma":[0.00011243487,0.0009089268,0.5273976,0.00922275,0.00028249616,0.224027,0.0020630436,0.0009127941,0.0011962679,0.004879551,0.22891407,0.000083067775],"about_ca_topic_score_codex":0.007589392,"about_ca_topic_score_gemma":0.0065990523,"teacher_disagreement_score":0.007589392,"about_ca_system_score_codex":0.0007380856,"about_ca_system_score_gemma":0.0014030781,"threshold_uncertainty_score":0.015090466},"labels":[],"label_agreement":null},{"id":"W2744176968","doi":"10.1007/s40506-017-0132-x","title":"Moving to a Dengue Preventive Treatment Through New Vaccines","year":2017,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Medicine; Dengue fever; myalgia; Dengue vaccine; Intensive care medicine; Dengue virus; Vaccination; Serotype; Immunization; Immunology; Virology; Immune system","score_opus":0.035052808790188204,"score_gpt":0.36221791235957024,"score_spread":0.32716510356938205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744176968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061769545,0.6280078,0.0297774,0.18717857,0.016852519,0.00059262617,0.0011332814,0.00043081713,0.07425746],"genre_scores_gemma":[0.26522857,0.5532844,0.047109786,0.07200205,0.01678289,0.00062871864,0.0016718747,0.00006334108,0.043228433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966,0.00010126307,0.000037340025,0.000035569738,0.00008744661,0.00007838656],"domain_scores_gemma":[0.9995173,0.00014089778,0.00008459306,0.00003757509,0.00013502227,0.000084670144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001196811,0.0004628881,0.0006469088,0.00044583934,0.00026199143,0.0011910592,0.00045142832,0.0009371864,0.01114435],"category_scores_gemma":[0.0010099212,0.00013475138,0.0006440117,0.00021515938,0.00054590456,0.0019446568,0.00059022504,0.0027479462,0.0015242302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048702201,0.001465666,0.0045179953,0.001812897,0.00023716415,0.0003160152,0.00015196987,0.0009025405,0.019390743,0.02736548,0.06359591,0.8797566],"study_design_scores_gemma":[0.0006877804,0.0033894149,0.012208028,0.003615293,0.0005206732,0.0011769779,0.00064612064,0.0011891205,0.012983838,0.020505687,0.9430041,0.00007293922],"about_ca_topic_score_codex":0.00077318266,"about_ca_topic_score_gemma":0.0016722638,"teacher_disagreement_score":0.01114435,"about_ca_system_score_codex":0.00059457,"about_ca_system_score_gemma":0.0016021271,"threshold_uncertainty_score":0.037281513},"labels":[],"label_agreement":null},{"id":"W2758893830","doi":"10.1007/s40506-017-0135-7","title":"Treatment of Latent Tuberculosis Infection","year":2017,"lang":"en","type":"review","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control","funders":"","keywords":"Medicine; Latent tuberculosis; Tuberculosis; Intensive care medicine; Context (archaeology); Isoniazid; Regimen; Pharmacotherapy; Adverse effect; Chemoprophylaxis; Mycobacterium tuberculosis; Pediatrics; Internal medicine; Pathology","score_opus":0.13789559411260688,"score_gpt":0.44727701136677583,"score_spread":0.30938141725416896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758893830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020055567,0.9958668,0.00017193121,0.00045181654,0.00033935253,0.0000204088,0.00006522126,0.000015465635,0.002868502],"genre_scores_gemma":[0.003217468,0.99403834,0.00033339017,0.00064570963,0.00037670866,0.000029523875,0.00016055444,0.000003911388,0.0011944572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995028,0.0001399396,0.00007569895,0.00006874717,0.00015857839,0.000054311135],"domain_scores_gemma":[0.99949884,0.0002528617,0.00009677666,0.00002386029,0.00009188426,0.000035754445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006519514,0.0007144065,0.0012295259,0.0021167526,0.00031854998,0.0009458137,0.0011552573,0.0012688688,0.008231729],"category_scores_gemma":[0.0018240701,0.00015430686,0.000954502,0.0010394541,0.00048975536,0.00096509175,0.00075973826,0.0017186324,0.002876962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086654356,0.00012804657,0.0003556893,0.02847987,0.00015745309,0.0002842924,0.000090920956,0.00020675985,0.0010759874,0.0031767585,0.05307436,0.9128832],"study_design_scores_gemma":[0.00005187572,0.00014135036,0.0013520826,0.0152993845,0.00018842716,0.002634411,0.00008154964,0.00007812983,0.000591024,0.001954253,0.97760993,0.000017521359],"about_ca_topic_score_codex":0.0011911892,"about_ca_topic_score_gemma":0.0016007867,"teacher_disagreement_score":0.008231729,"about_ca_system_score_codex":0.00058501255,"about_ca_system_score_gemma":0.0011014552,"threshold_uncertainty_score":0.027537882},"labels":[],"label_agreement":null},{"id":"W2802702101","doi":"10.1007/s40506-018-0173-9","title":"Recent Advances in the Diagnosis of Neurocysticercosis","year":2018,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Parasitic infections in humans and animals","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Neurocysticercosis; Taenia solium; Medicine; Pathognomonic; Neglected tropical diseases; Neuroimaging; Cysticercosis; Parasitic disease; Disease; Diagnostic test; Intensive care medicine; Pathology; Pediatrics; Psychiatry","score_opus":0.04659823860696624,"score_gpt":0.3724675190222578,"score_spread":0.3258692804152915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802702101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01357228,0.95320606,0.013437135,0.007715017,0.0017090717,0.000070939604,0.00022742971,0.00020733441,0.0098547265],"genre_scores_gemma":[0.12581345,0.82327455,0.03415645,0.004585725,0.007850658,0.000097388904,0.0010771495,0.00006661174,0.0030780802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829334,0.0005373311,0.0002329168,0.00030047624,0.0004753116,0.0001606137],"domain_scores_gemma":[0.99246407,0.003664742,0.00076736405,0.00033579455,0.0023032548,0.00046478063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00301075,0.00089180033,0.0015859704,0.0048744944,0.0004775037,0.0021946023,0.0014903274,0.00140942,0.002871759],"category_scores_gemma":[0.0058571585,0.0004826797,0.00084771967,0.0015988674,0.0015016005,0.00269122,0.00087129173,0.0025571892,0.0017417156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004902775,0.00024815573,0.017264657,0.005672606,0.00014835958,0.0021241968,0.00022848407,0.0005684141,0.012714205,0.001896657,0.011069245,0.94757473],"study_design_scores_gemma":[0.00021143183,0.001780603,0.07368469,0.01471741,0.002292703,0.094378226,0.0023893577,0.011979241,0.032224473,0.019218437,0.74665344,0.00046996685],"about_ca_topic_score_codex":0.003457415,"about_ca_topic_score_gemma":0.004241994,"teacher_disagreement_score":0.0048744944,"about_ca_system_score_codex":0.0010991115,"about_ca_system_score_gemma":0.0013684592,"threshold_uncertainty_score":0.015922546},"labels":[],"label_agreement":null},{"id":"W2914258368","doi":"10.1007/s40506-019-0181-4","title":"Bacterial Antibiotic Resistance: on the Cusp of a Post-antibiotic World","year":2019,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Medicine; Antibiotic resistance; Antibiotics; Acinetobacter baumannii; Microbiome; Intensive care medicine; Antimicrobial stewardship; Disease; Staphylococcus aureus; Infectious disease (medical specialty); Pseudomonas aeruginosa; Acinetobacter; Microbiology; Bacteria; Biology; Bioinformatics; Internal medicine; Genetics","score_opus":0.014969779718526883,"score_gpt":0.2860316026859621,"score_spread":0.27106182296743525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914258368","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00983245,0.56982243,0.0074630002,0.38205582,0.009779786,0.000027886419,0.00009755853,0.0002391809,0.020681905],"genre_scores_gemma":[0.14190625,0.7166827,0.010739356,0.10081787,0.018520214,0.0000705601,0.00015783,0.0001796993,0.01092553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966248,0.0011052211,0.00029732895,0.0002982673,0.0012485783,0.0004257351],"domain_scores_gemma":[0.9918562,0.0031320786,0.0011290462,0.0004369243,0.0019884186,0.0014572834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062013716,0.0006575471,0.0017058474,0.0011782179,0.0014499866,0.0075483844,0.0010870497,0.0055522094,0.0065778894],"category_scores_gemma":[0.006391621,0.00034062038,0.0005580606,0.00075642887,0.007191054,0.0116932085,0.0039350037,0.008984082,0.0017771494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063017826,0.0005205503,0.004146047,0.004151608,0.00014588289,0.0015452384,0.0020926106,0.00060617935,0.012710476,0.2834275,0.13495266,0.55507106],"study_design_scores_gemma":[0.00006954657,0.00081909756,0.0039463826,0.0035804256,0.00008245591,0.0030696027,0.0028006255,0.00065163366,0.0034499224,0.105362,0.87603617,0.00013204117],"about_ca_topic_score_codex":0.0005755597,"about_ca_topic_score_gemma":0.0013790315,"teacher_disagreement_score":0.0075483844,"about_ca_system_score_codex":0.0018920259,"about_ca_system_score_gemma":0.0036784199,"threshold_uncertainty_score":0.032796383},"labels":[],"label_agreement":null},{"id":"W2944131976","doi":"10.1007/s40506-019-00189-2","title":"Antimicrobial Stewardship in Patients with Hematological Malignancies: Key Considerations","year":2019,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sinai Health System","funders":"","keywords":"Antimicrobial stewardship; Medicine; Intensive care medicine; Antimicrobial; Febrile neutropenia; Neutropenia; Population; Stewardship (theology); Hematology; Internal medicine; Antibiotics; Antibiotic resistance; Environmental health; Chemotherapy; Microbiology","score_opus":0.020787865470059338,"score_gpt":0.2910746403931385,"score_spread":0.2702867749230792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944131976","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02594159,0.39413422,0.0042486503,0.5478305,0.0048337197,0.00007755677,0.00020901066,0.00009891549,0.022625713],"genre_scores_gemma":[0.5008942,0.32140458,0.019435372,0.11655215,0.037093185,0.00026520932,0.00053951325,0.00007551426,0.0037403223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711704,0.0011150232,0.0005515119,0.0002849103,0.00062303466,0.00030840747],"domain_scores_gemma":[0.990475,0.0038638802,0.0014379742,0.00015810995,0.0017158084,0.0023491413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002755288,0.00027606156,0.0010715864,0.00062516704,0.00080941257,0.0038562007,0.00081861235,0.002191371,0.00424263],"category_scores_gemma":[0.018502107,0.000188061,0.000817858,0.0006049451,0.0006418114,0.0029934493,0.0016820665,0.0053207483,0.0006148774],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037144948,0.00056456565,0.09152386,0.0027847234,0.0005341234,0.0023632108,0.0008811796,0.0011017676,0.0007987727,0.01219258,0.15630671,0.730577],"study_design_scores_gemma":[0.00039427113,0.0015501572,0.18880449,0.049519505,0.0013424183,0.019794371,0.011468452,0.0050447355,0.0011998684,0.065067925,0.6554775,0.00033634275],"about_ca_topic_score_codex":0.0020857798,"about_ca_topic_score_gemma":0.0077303792,"teacher_disagreement_score":0.00424263,"about_ca_system_score_codex":0.0012922481,"about_ca_system_score_gemma":0.00581689,"threshold_uncertainty_score":0.014571488},"labels":[],"label_agreement":null},{"id":"W2963223674","doi":"10.1007/s40506-019-00202-8","title":"Diagnosis and Treatment of Carbapenemase-Producing Organisms—an Update","year":2019,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Intensive care medicine; Meropenem; Avibactam; Observational study; Aztreonam; Cefepime; Clinical trial; Carbapenem; Randomized controlled trial; Imipenem; Antibiotic resistance; Internal medicine; Antibiotics; Ceftazidime; Pseudomonas aeruginosa","score_opus":0.016949857133527566,"score_gpt":0.2961454344698177,"score_spread":0.27919557733629013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963223674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036157496,0.99504954,0.0005352566,0.0018519807,0.0008581335,0.000008874319,0.000036320638,0.000026015974,0.0012722336],"genre_scores_gemma":[0.0020514426,0.99225473,0.0013483475,0.0016115292,0.0020206224,0.000011987099,0.00012347664,0.000006098833,0.0005717651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994331,0.00010651435,0.000121883,0.00006401948,0.00022734483,0.000047164638],"domain_scores_gemma":[0.9979493,0.0010040598,0.00029441016,0.000039310056,0.0005567536,0.00015620461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010883777,0.0008426115,0.0015913813,0.0022687388,0.00024071652,0.001738055,0.001005972,0.0015884587,0.0030923395],"category_scores_gemma":[0.0027164605,0.0003334628,0.00082652416,0.0013479044,0.00053635053,0.0020883419,0.00062534434,0.0023896236,0.0014801451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017492821,0.0001399427,0.000930573,0.0060499883,0.00008623831,0.00051972957,0.000034680586,0.00025725068,0.0011876993,0.0008599342,0.043499332,0.9462598],"study_design_scores_gemma":[0.00012374223,0.0003840368,0.0037862374,0.008622591,0.0005087428,0.007280354,0.00012578597,0.0005201318,0.0010678202,0.0017380744,0.97578454,0.000058061953],"about_ca_topic_score_codex":0.0014452321,"about_ca_topic_score_gemma":0.0031313745,"teacher_disagreement_score":0.0030923395,"about_ca_system_score_codex":0.0006783162,"about_ca_system_score_gemma":0.0014105969,"threshold_uncertainty_score":0.010344923},"labels":[],"label_agreement":null},{"id":"W2987020709","doi":"10.1007/s40506-019-00205-5","title":"Treatment of Non-Aspergillus Mold Infections: a Focus on Mucormycosis and Fusariosis","year":2019,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"","keywords":"Posaconazole; Fusariosis; Mucormycosis; Medicine; Voriconazole; Amphotericin B; Zygomycosis; Aspergillosis; Intensive care medicine; Antifungal; Dermatology; Surgery; Immunology; Biology; Fusarium","score_opus":0.020697077614028135,"score_gpt":0.31769433116049345,"score_spread":0.29699725354646533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987020709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005567726,0.9846155,0.0015948145,0.0034860487,0.0005077216,0.000021471145,0.00002039393,0.00003446871,0.004151791],"genre_scores_gemma":[0.0681052,0.9196869,0.0032832057,0.0031317933,0.0028379033,0.00003126267,0.00007805249,0.000019090558,0.002826535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997813,0.000055911263,0.000031485262,0.00003256188,0.0000594113,0.000039373208],"domain_scores_gemma":[0.99959356,0.00014333775,0.00010191219,0.000013429177,0.00008635197,0.000061382634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046711758,0.00045701393,0.0007712429,0.00089471415,0.00019773874,0.00065284857,0.00040436737,0.00071421894,0.002231494],"category_scores_gemma":[0.0005602978,0.00009796797,0.00057137123,0.00043924924,0.0003228013,0.00074348814,0.0005007037,0.0013609364,0.0003572963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025431084,0.0002918668,0.0014017819,0.0037113426,0.000092122245,0.0010931225,0.00008051814,0.00029833833,0.011576255,0.0024625605,0.011096222,0.9676416],"study_design_scores_gemma":[0.00027136283,0.0038211423,0.02313238,0.009406018,0.00050757726,0.025743263,0.00040346547,0.0014651818,0.009481915,0.0050493367,0.92064035,0.000077998135],"about_ca_topic_score_codex":0.00046634994,"about_ca_topic_score_gemma":0.0017835263,"teacher_disagreement_score":0.002231494,"about_ca_system_score_codex":0.0003396651,"about_ca_system_score_gemma":0.0005052253,"threshold_uncertainty_score":0.007465124},"labels":[],"label_agreement":null},{"id":"W4386571362","doi":"10.1007/s40506-023-00267-6","title":"Antibacterial Alternatives to a Dying Antibiotic Pipeline","year":2023,"lang":"en","type":"article","venue":"Current treatment options in infectious diseases/Current treatment options in infectious disease","topic":"Antimicrobial agents and applications","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Antimicrobial; Antibiotics; Medicine; Antibiotic resistance; Pathogenic bacteria; Bacteria; Anti-Infective Agents; Intensive care medicine; Microbiology; Biotechnology; Biology","score_opus":0.03309056311980733,"score_gpt":0.33134341768485054,"score_spread":0.2982528545650432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386571362","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016307047,0.48501042,0.024837004,0.2859097,0.020013615,0.00013142057,0.00038905296,0.00063719146,0.16676456],"genre_scores_gemma":[0.2905649,0.48141807,0.022774383,0.090266705,0.017348105,0.00024880792,0.00046030505,0.00033222386,0.09658649],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988997,0.00033566088,0.00004886383,0.00009872808,0.0004388076,0.00017821376],"domain_scores_gemma":[0.99862635,0.00040272778,0.00015489121,0.00012306268,0.00032079915,0.0003721378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022679437,0.0005723843,0.0006472588,0.000757101,0.0010240966,0.0031104644,0.001048,0.0023431757,0.022863662],"category_scores_gemma":[0.0024544916,0.00023148548,0.00052935834,0.00038232616,0.0030816933,0.0065033142,0.003089244,0.0065504387,0.004382243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064745615,0.00037643596,0.00031318906,0.0019557283,0.000051546966,0.00051122933,0.0004545305,0.0007640642,0.011861446,0.47118652,0.15825538,0.3536225],"study_design_scores_gemma":[0.000067414,0.00039265558,0.00017666485,0.00063771714,0.000024353176,0.0004124216,0.00033529592,0.00043900294,0.0024144459,0.11155515,0.8835237,0.000021251308],"about_ca_topic_score_codex":0.00033633242,"about_ca_topic_score_gemma":0.00088704436,"teacher_disagreement_score":0.022863662,"about_ca_system_score_codex":0.0011359677,"about_ca_system_score_gemma":0.0022271145,"threshold_uncertainty_score":0.07648653},"labels":[],"label_agreement":null}]}